{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:32:51Z","timestamp":1786991571237,"version":"build-2736575974"},"reference-count":40,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"no funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/21645515.2021.1979847","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T16:00:24Z","timestamp":1635523224000},"page":"5114-5119","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Reporting of recombinant adenovirus-based COVID-19 vaccine adverse events in online versions of three highly circulated US newspapers"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4862-4229","authenticated-orcid":false,"given":"Corey H.","family":"Basch","sequence":"first","affiliation":[{"name":"William Paterson University","place":["Wayne, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4331-9161","authenticated-orcid":false,"given":"Aleksandar","family":"Kecojevic","sequence":"additional","affiliation":[{"name":"William Paterson University","place":["Wayne, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-309X","authenticated-orcid":false,"given":"Victoria H.","family":"Wagner","sequence":"additional","affiliation":[{"name":"The State University of New Jersey","place":["New Brunswick, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"Johns Hopkins University. COVID-19 dashboard; 2021 [accessed 2021 Jul 7]. https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"e_1_3_2_3_1","unstructured":"World Health Organization (WHO). The effects of virus variants on COVID-19 vaccines; 2021 [accessed 2021 Jul 7]. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-effects-of-virus-variants-on-covid-19-vaccines?gclid=CjwKCAjwoNuGBhA8EiwAFxomA5sAy_gJ2N5fP5fgIyJRGjThpJYUIGAc6m_1ENEE5wvAlgjAz1JoFxoCV0UQAvD_BwE."},{"key":"e_1_3_2_4_1","unstructured":"World Health Organization (WHO). Coronavirus Disease (COVID-19); n.d. [accessed 2021 Jul 7]. https:\/\/extranet.who.int\/pqweb\/vaccines\/covid-19-vaccines."},{"key":"e_1_3_2_5_1","unstructured":"United States Food and Drug Administration. FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine; 2020 [accessed 2021 Jul 7]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19."},{"key":"e_1_3_2_6_1","unstructured":"United States Food and Drug Administration. Moderna COVID-19 vaccine; 2021 [accessed 2021 Jul 7]. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/moderna-covid-19-vaccine."},{"key":"e_1_3_2_7_1","unstructured":"United States Food and Drug Administration. Janssen COVID-19 vaccine; 2021 [accessed 2021 Jul 7]. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/janssen-covid-19-vaccine."},{"key":"e_1_3_2_8_1","unstructured":"Brueck H Dunn A. Business insider Why Johnson & Johnson\u2019s COVID-19 vaccine is probably the best shot; 2021 [accessed 2021 Jul 7]. https:\/\/www.businessinsider.com\/johnson-and-johnson-covid-19-vaccine-arguably-the-best-2021-2."},{"key":"e_1_3_2_9_1","unstructured":"Brueck H. Business insider. How does Johnson & Johnson\u2019s COVID-19 vaccine stack up against shots from Pfizer and Moderna?; 2021 [accessed 2021 Jul 7]. https:\/\/www.businessinsider.com\/coronavirus-vaccines-compared-pfizer-moderna-johnson-and-johnson-2021-1."},{"key":"e_1_3_2_10_1","unstructured":"Centers for Disease Control and Prevention. Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine; 2021 [accessed 2021 Jul 7]. https:\/\/www.cdc.gov\/media\/releases\/2021\/s0413-JJ-vaccine.html."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7017e4"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7018e2"},{"key":"e_1_3_2_13_1","unstructured":"Centers for Disease Control and Prevention. Vaccine Adverse Event Reporting System (VAERS); 2021 [accessed 2021 Jul 7]. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/vaers.html."},{"key":"e_1_3_2_14_1","unstructured":"The White House. Press briefing by White House COVID-19 response team and public health officials transcript from April 14 2021; 2021 [accessed 2021 Jul 7]. https:\/\/www.whitehouse.gov\/briefing-room\/press-briefings\/2021\/04\/14\/press-briefing-by-white-house-covid-19-response-team-and-public-health-officials-28\/."},{"key":"e_1_3_2_15_1","unstructured":"Almasy S Maxouris C. CNN. NIH director says J & J vaccine pause will give researchers time to do more study on certain groups; 2021 [accessed 2021 Jul 7]. https:\/\/www.cnn.com\/2021\/04\/14\/health\/us-coronavirus-wednesday\/index.html"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.25.101802.123046"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2020.560828"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapro\/dau028"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10453"},{"key":"e_1_3_2_20_1","unstructured":"National institutes of health plain language at NIH; n.d. [accessed 2021 Jul 7]. https:\/\/www.nih.gov\/institutes-nih\/nih-office-director\/office-communications-public-liaison\/clear-communication\/plain-language."},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2020.08.010"},{"key":"e_1_3_2_22_1","unstructured":"Agility. Top 10 US newspapers by circulation. [accessed 2021 Jul 7]. https:\/\/www.agilitypr.com\/resources\/top-media-outlets\/top-10-daily-american-newspapers\/."},{"key":"e_1_3_2_23_1","unstructured":"The New York Times 2020 annual report. [accessed 2021 August 19]. https:\/\/nytco-assets.nytimes.com\/2021\/03\/Final-NYT-2020-Annual-Report.pdf."},{"key":"e_1_3_2_24_1","unstructured":"Gannett Co. Annual report. [accessed 2021 August 19]. https:\/\/d18rn0p25nwr6d.cloudfront.net\/CIK-0001579684\/738c2ddb-7f33-48c7-80f9-0c2a79094433.pdf."},{"key":"e_1_3_2_25_1","unstructured":"NewsCorp annual report. [accessed 2021 August 19]. https:\/\/investors.newscorp.com\/static-files\/dc8c7cee-bb03-4571-a036-b1418af9821c."},{"key":"e_1_3_2_26_1","volume-title":"Web application for managing, analyzing, and presenting qualitative and mixed method research data","author":"Dedoose Version 8.0.35","year":"2018","unstructured":"Dedoose Version 8.0.35. Web application for managing, analyzing, and presenting qualitative and mixed method research data. Los Angeles (CA): SocioCultural Research Consultants, LLC; 2018. www.dedoose.com."},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1177\/160940690600500107"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049732315602867"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1079"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.2196\/publichealth.9544"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.02.005"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100223"},{"key":"e_1_3_2_33_1","unstructured":"United States Food and Drug Administration. FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review; 2021 [accessed 2021 Jul 7]. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-and-cdc-lift-recommended-pause-johnson-johnson-janssen-covid-19-vaccine-use-following-thorough."},{"key":"e_1_3_2_34_1","unstructured":"United States Food and Drug Administration. Janssen letter granting EUA amendment; 2021 [accessed 2021 Jul 7]. https:\/\/www.fda.gov\/media\/147865\/download."},{"key":"e_1_3_2_35_1","unstructured":"Centers for Disease Control and Prevention (CDC). Johnson & Johnson\u2019s Janssen COVID-19 vaccine overview and safety; 2021 [accessed 2021 Jul 7]. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/janssen.html."},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17218136"},{"key":"e_1_3_2_37_1","volume-title":"The pursuit of public journalism: theory, practice, and criticism","author":"Haas T","year":"2007","unstructured":"Haas T. The pursuit of public journalism: theory, practice, and criticism. New York (NY, USA): Routledge; 2007."},{"key":"e_1_3_2_38_1","unstructured":"World Health Organization (WHO). Understanding the infodemic and misinformation in the fight against COVID-19. [accessed 2021 August 16]. https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/52052\/Factsheet-infodemic_eng.pdf?sequence=14."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17176330"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-020-00913-w"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cyaa031"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1979847","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2021.1979847","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1979847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:22:14Z","timestamp":1786990934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1979847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/21645515.2021.1979847"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1979847","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-07-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}